drugset / Trial / NCT06141317

Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)

NCT06141317 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the safety and efficacy of allogenic pluripotent stem cells isolated from adipose tissue (PASCs) in patients with Parkinson's Disease.

Timeline

Start
2023-06-23
Primary completion
2024-09-01
Completion
2024-11-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Pluripotent Adipose-Derived Stem Cells Cell therapy 2.5e+07 cells Intravenous

Indications